Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health is naming its longtime executive David Joyner as its new CEO, succeeding Karen Lynch at the helm of the struggling healthcare giant, the Wall Street Journal reported on Friday.

CVS to name long-time exec David Joyner as new CEO, WSJ reports

This offering for self-insured customers is designed to further reduce health care costs, improve health outcomes and simplify the health care experience HARTFORD, Conn. , Oct. 16, 2024 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), now offers SimplePay Health, an alternative health plan designed to further meet the diverse needs of our clients and members.

Aetna introduces SimplePay Health

CVS Health (NYSE: CVS, $67.46, Market Capitalization: $84.86 billion), a leading health solutions company in the US, is considering a potential break-up to separate its retail and insurance units. As per media articles on October 07, 2024, management has been discussing various options with its financial advisers in recent weeks and said the possibility of splitting the pharmacy chain from the insurance business – Aetna has been discussed with the board of directors.

CVS Health May Spin-Off Insurance Business

CVS Health Co. NYSE: CVStransformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company when it acquired Aetna Health Insurance for $70 billion on November 28, 2018. The plan was to offer the full gamut of healthcare services and products and grow its Minute Clinics around the country, cashing in on primary care services.

CVS Health: Are Its Parts Worth More Than the Whole?

CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care for Most consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I. , Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released the Rx Report: Transforming Community Pharmacy to Make Healthier Happen Together , which explores the ongoing evolution of community pharmacy as well as opportunities for the industry to keep pace with consumer expectations, better support the workforce and advance the pharmacy model to create a more viable, sustainable future for the industry.

New CVS Health® report explores ongoing transformation of community pharmacy

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.

Exclusive: CVS to exit core infusions services business, job cuts possible

Aetna to support more Michigan residents eligible for both Medicare and Medicaid DETROIT , Oct. 11, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to serve MI Coordinated Health beneficiaries who are eligible for both Medicare and Medicaid. Aetna was selected as part of a competitive bidding process.

Aetna recommended for new D-SNP contract by the State of Michigan

Humana

UnitedHealth Group

Rival healthcare providers could gain from the cut in stars rating for Humana's Medicare plans.

Humana Stock Slumps. CVS and UnitedHealth Could Pick Up the Pieces.

Exceptional service results in highest-ever Aetna member experience score  WOONSOCKET, R.I. , Oct. 10, 2024 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that 88 percent of its Medicare Advantage (MA) members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans that are rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS).

Aetna shines in Star Ratings with 88 percent of Medicare Advantage members in 4-star plans or higher for 2025

CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.

CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst

Cigna

The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.

CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias

CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.

CVS, UnitedHealth ask for FTC's Khan and 2 commissioners to be disqualified from case

Pfizer

Activists appear to be calling a bottom on the two stocks.

Pfizer and CVS Are Attracting Activists. Healthcare Stocks Could Rebound.

Best Buy

Brookdale Senior Living

Ensign Group

Kamala Harris wants Medicare to change and cover long-term home care services, such as in-home aides. The plan creates uncertainty for Brookdale Senior Living and Ensign Group.

Harris Wants More Senior Care in the Home. Which Stocks Win or Lose.

WOONSOCKET, R.I. , Oct. 8, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Hurricane Milton's landfall in Florida tomorrow.

CVS Health supporting customers, patients, members and colleagues as Hurricane Milton approaches

WOONSOCKET, R.I. , Oct. 7, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m.

CVS Health to hold third quarter 2024 earnings conference call

Major changes could soon be coming, but will they drive the stock up?

Does This New Development Make CVS Stock a Buy or a Sell?

The stock could be poised for a turnaround.

Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?

On October 4, 2024, TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a potential upside of 35%, driven by significant updates to CVS's Medicare Advantage (MA) business.

Why CVS Health stock could appreciate 35% from here

We also chat about Uber and its quest to become an everything app.

An Activist Investor Is Interested in CVS; We Take a Look

Shares of CVS Health Corp (NYSE:CVS) are 3.9% higher to trade at $65.40 at last glance, after several updates for the healthcare giant.

CVS Health Stock Bounces on Company Updates

Changes in in the retail pharmacy's 2025 Medicare Advantage plan benefits should lower costs.

CVS Stock Can Gain 35% From Here, Analyst Says. Here's How.

Diamondback Energy

Morgan Stanley

M&T Bank

Williams

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

CVS has engaged advisors in a strategic review of its business, CNBC has reported Monday. One option being weighed is splitting up its retail pharmacy and insurance units.

News for CVS Health Stock (CVS)